BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
November 13, 2013
Franklin Lakes, NJ and Boston, MA –– BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has joined the National Patient Safety Foundation (NPSF) Corporate Council. The membership will enable BD to work alongside the Foundation and its constituent groups, including healthcare providers, other service and product providers, [...]
Utrecht University Appoints Makarov Professor of High Resolution Mass Spectrometry
November 13, 2013
UTRECHT, The Netherlands –The Executive Board of Utrecht University, by special appointment, named Alexander Makarov, Ph.D, professor of high resolution mass spectrometry at the Bijvoet Center of the Department of Chemistry. Makarov is Director of Global Research, Life Science Mass Spectrometry (LSMS) for Thermo Fisher Scientific. “I hope this appointment will become a bridge that [...]
Chiral Technologies Announces i-CHIRAL 4
November 13, 2013
WEST CHESTER, Pa. — Chiral Technologies announced today the availability of i-CHIRAL 4, a set of four Daicel 3-µm immobilized CSPs – CHIRALPAK® IA, IB, IC and ID – packed in columns of 4.6 mm internal diameter and 150 mm long. This combination of columns will raise method development success rates to greater than 89 [...]
November 13, 2013
NEW YORK -- Kem-En-Tec Diagnostics, a world leader in developing environmentally safe, technologically advanced, and ready-to-use components for immunoassays, announced today that the company will be presenting at MEDICA 2013, in Düsseldorf, Germany November 20-23, 2013. Kem-En-Tec Diagnostics is also celebrating the company’s 25th Anniversary during its participation at the largest medical exhibition in the [...]
November 13, 2013
BILLERICA, Mass. –– RainDance Technologies, Inc. today announced that it has added a High-Precision Chromosomal Copy Number Variation (CNV) Measurement application to its industry-leading RainDrop™ Digital PCR System. The latest application provides researchers with a simple and highly accurate method of detecting low frequency chromosomal CNVs and trisomy events from circulating tumor cells or cell-free [...]
November 13, 2013
PHOENIX, Arizona; REDWOOD CITY, California; and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has begun enrolling molecular diagnostics laboratories in an Early Access Program to complete the development of a new web-based solution to deliver faster, easier-to-use and high-confidence clinical interpretation and reporting of observed gene variants in [...]
Maverix Biomics Forms Strategic Co-Marketing Alliance with QIAGEN
November 13, 2013
PHOENIX -- Maverix Biomics Inc., today announced at the Association of Molecular Pathology (AMP) 2013 Annual Meeting in Phoenix, Arizona that the company has signed a non-exclusive strategic co-marketing agreement with QIAGEN to streamline the interpretation of raw next-generation sequencing (NGS) data into meaningful and actionable insights. The Maverix Analytic Platform will complement QIAGEN's sample-to-insight [...]
New Collaboration with Industrial Customer Expands NPPD’s Renewable Energy Portfolio
November 13, 2013
Columbus, Nebraska – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Nebraska Public Power District (NPPD) announced today an agreement to purchase renewable energy credits from NextEra Energy Resources’ Steele Flats Wind Farm for the next 20 years. Energy from the recently completed 75-megawatt Steele Flats Wind Farm, located [...]
November 13, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced the IQFISH FFPE Hybridization buffer, which enables one-hour hybridization for FISH processing on formalin fixed paraffin embedded (FFPE) tissue samples. The IQ technology, originally developed by Dako, was previously available only to anatomic pathology labs. Now, with the IQFISH FFPE Hybridization buffer offered as [...]
November 12, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) has announced it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized CGH (comparative genomics hybridization) microarrays to researchers worldwide. Six new microarray designs unite the power of Baylor's data-rich expertise in genetics research with Agilent's microarray manufacturing capabilities to enable advanced [...]

